J 2024

Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study

STREBEL, Sven, Katja BAUST, Desiree GRABOW, Julianne BYRNE, Thorsten LANGER et. al.

Basic information

Original name

Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study

Authors

STREBEL, Sven, Katja BAUST, Desiree GRABOW, Julianne BYRNE, Thorsten LANGER, Antoinette Am ZEHNHOFF-DINNESEN, Rahel KUONEN, Annette WEISS, Tomáš KEPÁK, Jarmila KRUSEOVA, Claire BERGER, Gabriele CALAMINUS, Grit SOMMER and Claudia E KUEHNI

Edition

JOURNAL OF CANCER SURVIVORSHIP, New York, SPRINGER, 2024, 1932-2259

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 3.700 in 2022

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1007/s11764-023-01456-4

UT WoS

001069959900001

Keywords in English

Childhood cancer; Survivorship; Quality of life; Hearing loss; Tinnitus

Tags

14110132, 14110321
Změněno: 6/3/2024 09:21, Mgr. Tereza Miškechová

Abstract

V originále

PurposeAuditory complications are potential side effects from childhood cancer treatment. Yet, limited evidence exists about the impact of auditory complications-particularly tinnitus-on health-related quality of life (HRQoL) among childhood cancer survivors (CCS). We determined the prevalence of hearing loss and tinnitus in the European PanCareLIFE cohort of CCS and examined its effect on HRQoL.MethodsWe included CCS from four European countries who were diagnosed at age & LE; 18 years; survived & GE; 5 years; and aged 25-44 years at study. We assessed HRQoL (Short Form 36), hearing loss, and tinnitus using questionnaires. We used multivariable linear regression to examine associations between these two auditory complications and HRQoL adjusting for socio-demographic and clinical factors.ResultsOur study population consisted of 6,318 CCS (53% female; median age at cancer diagnosis 9 years interquartile range [IQR] 5-13 years) with median age at survey of 31 years (IQR 28-35 years). Prevalence was 7.5% (476/6,318; confidence interval [CI]: 6.9-8.2) for hearing loss and 7.6% (127/1,668; CI: 6.4-9.0) for tinnitus. CCS with hearing loss had impaired physical (coefficient [coef.] -4.3, CI: -7.0 to -1.6) and mental (coef. -3.2, CI: -5.5 to -0.8) HRQoL when compared with CCS with normal hearing. Tinnitus was associated with impaired physical (coef. -8.2, CI: -11.8 to -4.7) and mental (coef. -5.9, CI: -8.8 to -3.1) HRQoL.ConclusionWe observed reduced HRQoL among CCS with hearing loss and tinnitus. Our findings indicate timely treatment of hearing loss and tinnitus may contribute to quality of life of survivors.Implications for cancer survivorsCCS who experience auditory complications should be counseled about possible therapeutic and supportive measures during follow-up care.
Displayed: 10/11/2024 12:41